Close X
Thursday, November 14, 2024
ADVT 
National

No known link for AstraZeneca vaccine and clots

Darpan News Desk The Canadian Press, 12 Mar, 2021 08:30 PM
  • No known link for AstraZeneca vaccine and clots

Health Canada's chief medical adviser says there is no scientific explanation to suggest a link between the Oxford-AstraZeneca COVID-19 vaccine and blood clots.

Dr. Supriya Sharma says Health Canada has a "really low threshold" for adverse events that could trigger a pause on the use of a vaccine and wouldn't hesitate to do so if something warranted it.

A few European countries halted use of AstraZeneca's injection temporarily this week, and others suspended use of specific batches, after some adverse events, including blood clots, were reported following vaccination.

Health Canada says the vaccine remains safe and effective but will continue to monitor all adverse events.

Sharma says Health Canada has the reports and is looking for three things, including if there is a biological explanation for how the vaccine could have caused the blood clots.

She says there is none.

MORE National ARTICLES

Crown lawyer urges Meng's judge to ignore politics

Crown lawyer urges Meng's judge to ignore politics
Meng is wanted in the United States on fraud charges that both she and Huawei deny.

Crown lawyer urges Meng's judge to ignore politics

Vancouver makes plan to cut Canada goose numbers

Vancouver makes plan to cut Canada goose numbers
A statement from the Vancouver Board of Parks and Recreation says it is developing a management plan to reduce the number of geese in city parks, beaches and on the seawall.

Vancouver makes plan to cut Canada goose numbers

Air Canada holding to refund pledge: Unifor

Air Canada holding to refund pledge: Unifor
Air Canada reported in February it held onto $2.3 billion in advance ticket sales last quarter.

Air Canada holding to refund pledge: Unifor

Researchers looking at COVID-19 in teachers

Researchers looking at COVID-19 in teachers
About $2.9 million will be spent on the research in British Columbia, Ontario, and Quebec as part of the work of the national COVID-19 immunity task force.

Researchers looking at COVID-19 in teachers

Vaccines for variants won't take as long: Sharma

Vaccines for variants won't take as long: Sharma
The decision should help the regulator authorize the boosters for use in Canada much quicker and is in line with the process used to approve new flu vaccines each year.

Vaccines for variants won't take as long: Sharma

Extended dose intervals for COVID-19 vaccines to optimize early vaccine rollout and population protection in Canada

Extended dose intervals for COVID-19 vaccines to optimize early vaccine rollout and population protection in Canada
Current evidence suggests high vaccine effectiveness against symptomatic disease and hospitalization for several weeks after the first dose, including among older populations.

Extended dose intervals for COVID-19 vaccines to optimize early vaccine rollout and population protection in Canada